Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tilray

Want Exposure To The Canadian Recreational Cannabis Market? These Are The 3 Best Picks, According To A Cantor Analyst

In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald offered an update on the performance of Canada’s cannabis Licensed Producers in the August quarter, based on data obtained by the market scanner Hifyre.

Benzinga

Cannabis Company Tilray Just Made a Major Blunder

A Tilray press release last week seems to have caused some dismay among Germany's drug regulators.

The Street

Cannabis News Week: German Imports, Tyson 2.0 on the Ropes

Germany is importing more weed for research purposes than it ever has in the past.

The Street

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Tilray A Buy Following Trump Social Media Post?

TLRY stock got a lift after Donald Trump said he supported lowering the classification of the drug. Is now the time to buy the cannabis stock?

Investors Business Daily

Tilray To Guide Patients On Their Medical Cannabis Journey, Launches New Products & 'CannaPoints' Program

Tilray Brands, Inc.’s (Nasdaq: TLRY) (TSX:TLRY) Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands and launched CannaPoints, a new program designed to support pa

Benzinga

Is Tilray Still A Bear Play Or Is The Cannabis Giant Ready For A Big Break North?

Tilray Brands, Inc (NASDAQ: TLRY) was spiking up over 6% on Monday, attempting to break up from a falling channel on the daily chart, which the stock began trading in on Aug. 8.

Benzinga

Why Does This Undervalued Cannabis Stock Have An Encouraging Outlook?

The Analyst

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Analysts Going Hard On Tilray, Slashing Price Targets; How Much Adj. EBITDA Really Improved?

Tilray Brands, Inc.

Benzinga

EXCLUSIVE: Tilray CEO Shares Insider Insights Into Earnings, International Opportunities, Alcohol Market & More

Tilray Brands Inc.'s (NASDAQ: TLRY) CEO Irwin Simon said on Thursday's "Cannabis Insider" that "Europe will legalize [cannabis] before the U.S."

Benzinga

Cannabis News Week: Tilray's Quarter, Brittney Griner Swap

The U.S. is proposing to trade a convicted Russian arms dealer for Griner and a Marine that has been in custody since 2018.

The Street

Tilray's Fiscal 2022 Revenue Grows 22% YoY, Here Are The Details

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) net revenue grew 8% to $153.3 million during the fourth quarter 2022, from $142.2 million in the prior year quarter.

Benzinga

What's Going On With Tilray Stock As Cannabis Legalization Bill Reaches Senate?

Tilray Brands, Inc (NASDAQ: TLRY) gapped up about 4.5% higher on Thursday on news that the Cannabis Administration And Opportunity Act (CAOA) has been introduced in the U.S. Senate.

Benzinga

Cannabis News Week: SAFE Banking Passes House (Again); New York Cracks Down

The SAFE Banking Act passed the House of Representatives for the seventh time this week. It now heads to the Senate where it will likely be defeated.

The Street

Tilray Goes Through With It: Closes $155M Investment In HEXO, Expects $80M In Shared Savings

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) has closed its acquisition from HT Investments MA LLC (“HTI”) of the secured convertible note issued by HEXO Corp. (NASDAQ: HEXO

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Tilray's Good Supply Brand Expands Its Cannabis Portfolio In Québec

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) cannabis brand Good Supply has expanded its product offering in Québec with the launch of Hash-Infused Pre-Rolls, in collaboration with the Société Québ&e

Benzinga

Tilray Will Cover Employees' Travel, Accommodation & Paid Time Off For Women Seeking Reproductive Care

Tilray Brands Inc. (NASDAQ: TLRY) is joining other companies that are committing to help their employees travel to other states, following SCOTUS' decision to overturn Roe v.

Benzinga

Tilray Medical Expands Portfolio Of Medical Cannabis Products In The UK

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom.

Benzinga

5 Value Stocks To Watch In The Healthcare Sector

What Defines a Value Stock?

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Sentiment For Tilray Stock Should Improve, This Analyst Tells Us Why

Germany is inching toward legalizing recreational cannabis as the government seeks to have the process completed by the end of 2022. The latest push is coming from the country’s Health Ministry which undertook exper

Benzinga

Read Why Cantor Upgraded Aurora Cannabis Stock

Cantor Fitzgerald has upgraded Aurora Cannabis Inc (NASDAQ: ACB) to Overweight from Neutral

Benzinga

Tilray's Medical Cannabis Facility Visited By Government Of Luxembourg Delegation

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) welcomed the Luxembourg Ministry of Health delegation to the company’s European campus and facility located in Cantanhede, Portugal.

The Street

It's a Cannabis Buyers' Market

Inventory issues are forcing major retailers to lower prices to clear backed up product.

Benzinga

HEXO Deal Could Be A Big Win For Tilray, This Analyst Tells Us Why

On Wednesday HEXO Corp (NASDAQ: HEXO) reported a staggering loss of CA$152.7 million ($118 million) in the third quarter of 2022, representing a

Benzinga

HEXO, Tilray Brands Amend Transaction Agreement, Here Are The Details

HEXO Corp. (TSX:HEXO) (NASDAQ: HEXO) has entered into an amending agreement to the transaction agreement with Tilray Brands, Inc. (NASDAQ:

Benzinga

Here's Why More Pain Looks Likely For Tilray Bulls

Tilray Inc (NASDAQ: TLRY) slipped to a new 52-week low on Thursday as the stock continued in a consistent 16-month downtrend that began in February 2021.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.